Intrexon reported $-25469000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Amgen AMGN:US $ 2378M 1550M
Anika Therapeutics ANIK:US $ 1.3M 7.88M
Arrowhead Research ARWR:US $ -64883000 33.02M
AstraZeneca AZN:LN -1674000000 2.8B
Bluebird Bio BLUE:US $ -216.95M 23.88M
Bristol Myers Squibb BMY:US $ 1996M 281M
Chemocentryx CCXI:US $ -21.8M 16.93M
Dicerna Pharmaceuticals DRNA:US $ -20.27M 19.97M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
Gilead Sciences GILD:US $ 3842M 1596M
GlaxoSmithKline GSK:LN 1.94B 263M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Immunogen IMGN:US $ -34.23M 6.86M
Intrexon XON:US $ -25.47M 9.8M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Ligand Pharmaceuticals LGND:US $ 15.61M 27.83M
Macrogenics MGNX:US $ -52987000 12.71M
Mannkind MNKD:US $ -1.66M 30.74M
Merk MRK:US $ 4826M 3212M
Novartis NOVN:VX 3.23B 246M
Peregrine Pharmaceuticals PPHM:US $ 4.15M 2.78M
Rigel Pharmaceuticals RIGL:US $ -19.78M 6.74M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Thermo Fisher Scientific TMO:US $ 2278M 115M
Veracyte VCYT:US $ -16.68M 9.21M
Xencor XNCR:US $ -41.9M 50.99M
YTE INCY:US $ 235.41M 94.57M
Ziopharm Oncology ZIOP:US $ -22296000 343K